Method Identifies Cancer Patients Who Benefit From Early Palliative Care
Patients who received early palliative care had improvements in symptom control and mood over time.
Lung Cancer
Artificial Intelligence May Speed Lung Cancer Detection
The AI technology was tested on 1,179 patients in a lung screening trial.
Global Impact of COVID-19 on Enrollment in Lung Cancer Trials
Enrollment declined 43% from 2019 to 2020.
Socioeconomic Status Does Not Predict Survival in Mesothelioma
Factors associated with poor survival were advanced age and male sex.
Lurbinectedin Plus Doxorubicin Improves PFS, Not OS, in Small-Cell Lung Cancer
The 12-month progression-free survival rate was superior in the lurbinectedin arm.
Durvalumab Plus Chemo Showed Continued Survival Benefit in Extensive-Stage SCLC
Updated results from the phase 3 CASPIAN study further established first-line durvalumab with platinum-etoposide as a standard of care for ES-SCLC.
Adding Immunotherapy to Chemo Improves Survival in Metastatic Non-Small Cell Lung Cancer
The combinations conferred benefits in nonsquamous non-small cell lung cancer only.
Sugemalimab Deemed Effective as Consolidation for Stage III Non-Small Cell Lung Cancer
Sugemalimab improved progression-free survival whether patients received sequential or concurrent chemoradiotherapy.
Adding Bevacizumab to Erlotinib Prolongs PFS in Non-Squamous Non-Small Cell Lung Cancer
There was no improvement in overall survival with bevacizumab.
Prostate Cancer Screenings Fell Sharply Early in COVID-19 Pandemic
The decrease in prostate cancer screening rates was the smallest among 5 cancers studied.
- Loading...
Loading...
Next post in AUA 2021
Loading... 
Loading...